Published by Josh White on 18th December 2020
(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.
URL: http://www.digitallook.com/dl/news/story/31526292/...